These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels. Grgic I; Kiss E; Kaistha BP; Busch C; Kloss M; Sautter J; Müller A; Kaistha A; Schmidt C; Raman G; Wulff H; Strutz F; Gröne HJ; Köhler R; Hoyer J Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14518-23. PubMed ID: 19706538 [TBL] [Abstract][Full Text] [Related]
12. Gal-3 (Galectin-3) and K She G; Hou MC; Zhang Y; Zhang Y; Wang Y; Wang HF; Lai BC; Zhao WB; Du XJ; Deng XL Hypertension; 2020 Feb; 75(2):393-404. PubMed ID: 31838908 [TBL] [Abstract][Full Text] [Related]
13. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy. Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813 [TBL] [Abstract][Full Text] [Related]
14. Blockade of KCa3.1 Attenuates Left Ventricular Remodeling after Experimental Myocardial Infarction. Ju CH; Wang XP; Gao CY; Zhang SX; Ma XH; Liu C Cell Physiol Biochem; 2015; 36(4):1305-15. PubMed ID: 26160442 [TBL] [Abstract][Full Text] [Related]
15. Klotho attenuates high glucose-induced fibronectin and cell hypertrophy via the ERK1/2-p38 kinase signaling pathway in renal interstitial fibroblasts. Huang JS; Chuang CT; Liu MH; Lin SH; Guh JY; Chuang LY Mol Cell Endocrinol; 2014 Jun; 390(1-2):45-53. PubMed ID: 24721634 [TBL] [Abstract][Full Text] [Related]